Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(MF) As of Jul 28, 2014 06:05 PM ET

 Add to portfolio

$192.61 USD

-2.04 (-1.05%)

Zacks MF Rank : 3 - Hold [?]     3    

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Jun 30, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Jun 30, 2014) 10.20
Objective* Health Care - Equity
Peer* HL MG

*Key

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Hold 3
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 44.23
Net Assets (Mil $) 6/30/2014 8,129.80
%Turnover 6/30/2014 35.00

Allocation

% of Portfolio
Large Growth 28.15
Large Value 0.00
Small Growth 8.37
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 26.26
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 6/30/2014 % of Portfolio
Health 54.09
Services 23.84
Other 14.58
Industrial Cyclical 7.17
Technology 0.32

Portfolio Holdings

Top Equity Holdings
(As of 2/28/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 13.34 1,471.57
AMGEN INC 9.16 1,010.48
BIOGEN IDEC INC 6.70 738.86
~INTERCEPT PHARMACEUTICAL 4.89 540.04
ALEXION PHARMACEUTICALS I 4.46 491.83
CELGENE CORP 4.19 462.17
REGENERON PHARMACEUTICALS 3.81 419.90
VERTEX PHARMACEUTICALS IN 2.99 329.57
BIOMARIN PHARMACEUTICAL 1.68 185.83

Stock Holding % of Net Assets

As Of 2/28/2014
Total Issues 167
Avg. P/E 41.60
Avg. P/Book 5.68
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 42,088

Risk

3 Year 5 Year 10 Year
Beta 0.93 0.99 0.79
Alpha 19.43 10.17 7.95
R Squared 0.28 0.40 0.34
Std. Dev. 21.57 21.14 20.25
Sharpe 1.78 1.49 2.00